Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Invasive Disease Caused by Group A Streptococcus (GAS) - a Prospective Study (DICAR)

NCT03507101 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT03507101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03507101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Invasive Disease Caused by Group A Streptococcus (GAS) - a Prospective Study (DICAR)
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2018
Completion date
December 31, 2024
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

invasive group a beta-haemolytic streptococcal disease